Immunology, oncology and neurology are predicted to drive the most growth in drug spending over the next five years. (Photo: Shutterstock)
Prescription drug use in the U.S. has returned to pre-pandemic levels, and cost trends for medications were flat or declining in 2021, according to a new study. However, out-of-pocket (OOP) costs to consumers continued to increase, the researchers found.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.